Post by
Accountprince on Jun 21, 2022 10:43am
AGM Disclosures
Hope some of the posters here took the time to listen to the AGM presentation. Some gems in the presentation that is available in SEDAR - I encourage each of you to get it and read it:
EAA and PMX - Baxter and Spectral working closely on pre-launch activities suggests Baxter much more enthused now. Kellum did add verbally to "exceeding expectations" that results are "greatly" - so putting it together you'd have "greatly exceeding expectations". The presentation also disclosed that they have submitted to the FDA for a "breakthrough designation". I am drawing a conclusion and path - how about the rest of you?
Dialco - the presentation talks about developing a "strategic partnership" to bring in funds directly. Kellum said progressing but discussions preclude disclosure of details at this time. That implies the discussions are more advanced that the "developing" stage. Sam Amory very impressive speaking and with what he's achieved in a very short period of time. Looks like Dialco has the goods and people to get there. Seto repeated his "when not if" for DIMI in terms of FDA approval.
This one didn't leave me feeling same old...same old...just the opposite
Comment by
mercedesman on Jun 21, 2022 10:56am
Correct AP And lets not forget that they are making endotoxins sexy again! Not that they ever were not a turn on for me. Working with FDA to increase # of sites to 25 – increase enrollment Sepsis cases increasing – enrollment increasing SOFA score protocol amendment – last 4 of 7 patients enrolled MM
Comment by
mercedesman on Jun 21, 2022 11:14am
Re: DIMI Usability Trial Under the heading of "confirmed" : University of Michigan "confirmed" (4 patients) Partner # 2 ("confirmed" ?!?!?!?!?) (6 sites, 20-30 patients) Two more Clinics/sites apparently in the works. How long will # 2 be kept a secret? I'm excited to know the answer ! MM
Comment by
mercedesman on Jun 21, 2022 11:53am
If # 2 is a big name and they participate (directly or indirectly) in the funding, I wouldn't want to be "out" of the stock when the news came out. I may even have to buy back some of the trading postion I sold on the recent "speculative" run-up. Anyone got Level II access? MM